Tara I. Chang
Publication Details
-
Use of secondary prevention medications among adults with reduced kidney function.
Clin J Am Soc Nephrol. 2012; (4): 604-11
Persons with kidney disease often have cardiovascular disease, but they are less likely to use recommended medications for secondary prevention. The hypothesis was that participants with reduced estimated GFR have lower use of medications recommended for secondary prevention of cardiovascular events (antiplatelet agents, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, β-blockers, and statins) and lower medication adherence than participants with preserved estimated GFR.
